National Cheng Kung University Hospita

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors	Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor	Recruiting	Phase 1 / Phase 2	2026-04-09		NCT05048901

Clinical trials